As of 2025-05-20, the Fair Value of Enlivex Therapeutics Ltd (ENLV) is -5.65 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.99 USD, the upside of Enlivex Therapeutics Ltd is -670.78%.
With the market price of 0.99 USD and our fair value calculation, Enlivex Therapeutics Ltd (ENLV) is not a good investment. Investing in ENLV stocks now will result in a potential loss of 670.78%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -11.82 | -14.47 | -31.06 | -29.07 | -15.01 | -20.29 |
| YoY growth | -26.01% | -22.42% | -114.65% | 6.41% | 48.35% | -21.66% |
| Market Cap (mil) | 21.77 |
| P/E | |
| Forward P/E |
| EPS | -1.13 |
| Avg earnings growth rate | -21.66% |
| TTM earnings | -24.85 |